- Home
- HYPR vs FORA Comparison
HYPR vs FORA Comparison
Compare HYPR & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYPR
- FORA
- Stock Information
- Founded
- HYPR 2014
- FORA 2014
- Country
- HYPR United States
- FORA United States
- Employees
- HYPR N/A
- FORA N/A
- Industry
- HYPR Medical Specialities
- FORA Computer Software: Prepackaged Software
- Sector
- HYPR Health Care
- FORA Technology
- Exchange
- HYPR Nasdaq
- FORA Nasdaq
- Market Cap
- HYPR 55.9M
- FORA 60.2M
- IPO Year
- HYPR N/A
- FORA N/A
- Fundamental
- Price
- HYPR $1.20
- FORA $2.08
- Analyst Decision
- HYPR Strong Buy
- FORA Strong Buy
- Analyst Count
- HYPR 3
- FORA 1
- Target Price
- HYPR $1.28
- FORA $5.00
- AVG Volume (30 Days)
- HYPR 363.4K
- FORA 69.2K
- Earning Date
- HYPR 08-13-2025
- FORA 08-13-2025
- Dividend Yield
- HYPR N/A
- FORA N/A
- EPS Growth
- HYPR N/A
- FORA N/A
- EPS
- HYPR N/A
- FORA N/A
- Revenue
- HYPR $10,797,000.00
- FORA $25,031,040.00
- Revenue This Year
- HYPR $12.92
- FORA $47.82
- Revenue Next Year
- HYPR $32.10
- FORA $10.11
- P/E Ratio
- HYPR N/A
- FORA N/A
- Revenue Growth
- HYPR N/A
- FORA 18.59
- 52 Week Low
- HYPR $0.53
- FORA $1.64
- 52 Week High
- HYPR $1.90
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- HYPR 51.58
- FORA 55.28
- Support Level
- HYPR $1.06
- FORA $2.06
- Resistance Level
- HYPR $1.28
- FORA $2.19
- Average True Range (ATR)
- HYPR 0.07
- FORA 0.17
- MACD
- HYPR -0.03
- FORA 0.02
- Stochastic Oscillator
- HYPR 50.00
- FORA 41.12
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.